Get Breaking Health News headlines emailed to you daily.
Pfizer Ends Study On Potential Lung Cancer Drug Source: The Seattle Times Friday 12th March, 2010
Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness. ...
